![Dong Song Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dong Song Wei
Bedrijfssecretaris bij SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Vermogen: 29 397 $ op 30-06-2024
Actieve functies van Dong Song Wei
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Bedrijfssecretaris | 09-01-2012 | - |
Corporate Officer/Principal | 18-08-2011 | 09-01-2012 | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Directeur/Bestuurslid | - | - |
Loopbaan van Dong Song Wei
Statistieken
Internationaal
China | 3 |
Operationeel
Corporate Officer/Principal | 1 |
Corporate Secretary | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Sinopharm YiXin Pharmaceutical Co., Ltd.
![]() Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
- Beurs
- Insiders
- Dong Song Wei
- Ervaring